Ten years after the 2016 UN General Assembly Special Session on drugs (UNGASS), a new report by the International Drug Policy Consortium takes stock of progress and remaining gaps in global drug policy. We spoke with Marie Nougier about what has changed over the past decade—and what still needs to change.

After 15 years at the helm of the International Drug Policy Consortium, Ann Fordham is stepping down as Executive Director. Under her leadership, IDPC has grown into one of the most influential global networks advocating for drug policies grounded in human rights, public health, and social justice. In this interview, we reflect on IDPC’s achievements, ongoing challenges, and what lies ahead.

Jeremy Rudy, founder of the Sabba Collective, explains how psychedelic therapy can be integrated into society safely and responsibly — from education to policy.

We spoke with Pavel Bém, a Czech psychiatrist and former mayor of Prague in Vienna during the 69th session of the Commission on Narcotic Drugs (CND) about the country’s latest reforms—from cannabis regulation to psychedelic therapy—and what they mean for the future of drug policy in Europe.

Civil society and drug user activists push harm reduction reforms across the Nordic region – please watch the videos from a side event at the UN Commission on Narcotic Drugs (CND) and learn more about drug policy reform in Scandinavia!

On February 28, thousands of people gathered in Budapest and three other Hungarian cities for an unusual form of protest: a peaceful demonstration expressed through electronic music and collective dancing against the increasingly harsh war on drugs.

Senator Jeff Steinborn is the sponsor of the Medical Psilocybin Act in New Mexico, a visionary step toward expanding access to psychedelic therapy. In this conversation, filmed at the Psychedelic Science 2025 conference in Denver, he discusses why legislative action was necessary, how to ensure inclusion for marginalized communities, and what benchmarks will define success as New Mexico opens its first healing centers.

Colorado is the second U.S. state to legalize the therapeutic use of psilocybin mushrooms. During the Psychedelic Science conference in June 2025, Drugreporter visited ETC Hospitality in Golden, Colorado — a newly licensed natural medicine healing center — to see how psilocybin-assisted psychotherapy will be practiced in real-world settings.

Explore key speeches and sessions recorded at the Scottish Drugs Forum’s annual conference in Glasgow.

This DUNews video is dedicated to three key topics that today determine the future of Ukrainian drug policy and the healthcare system: the use of psychoactive substances in the treatment of various conditions, the full-fledged legalization of medical cannabis and the introduction of national standards, as well as the revision of Order No. 188 on minimum dosages of psychoactive substances based on European recommendations.